Breast Cancer Detection
13
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
FAP PET/CT for Staging Patients With Breast Cancer
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Diagnostic Accuracy of Carebot AI MMG in Mammography Screening: Multicenter MRMC Study
The Study Will Enroll Females Who Are Coming in for Their Annual Mammogram Screening and Who Are Schedule for a Biopsy to Provide a Breath Sample Via a Mask to Evaluate if Breast Cancer Can be Detected.
Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria
UCF MammoChat: Image Repository
AI-Based Self-Supervised Learning Model Using Non-Contrast Breast MRI for Early Screening and Clinical Utility Evaluation
Molecular Breast Imaging (MBI)-Guided Biopsy
Early Detection of Breast Cancer Among Syrian Women
Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions Characterization
DWI Breast MRI in Dense Breast: A Clinical Trial to Assess the Efficacy and Diagnostic Accuracy of Diffusion Weighted Imaging in Dense Breast Tissue
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)
Delphinus SoftVue™ ROC Reader Study